Cliff Asness's LMAT Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 18,969 shares of LeMaitre Vascular, Inc. (LMAT) worth $1.54 M, representing 0.00% of the portfolio. First purchased in 2015-Q4, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in LMAT, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2017, adding 57,525 shares. Largest reduction occurred in Q4 2017, reducing 59,306 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's LeMaitre Vascular (LMAT) Holding Value Over Time
Track share changes against reported price movement
Quarterly LeMaitre Vascular (LMAT) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -2,177 | Reduce 10.30% | 18,969 | $81.10 |
| Q3 2025 | -6,162 | Reduce 22.56% | 21,146 | $87.51 |
| Q2 2025 | -570 | Reduce 2.04% | 27,308 | $83.05 |
| Q1 2025 | +7,445 | Add 36.44% | 27,878 | $83.90 |
| Q4 2024 | -2,640 | Reduce 11.44% | 20,433 | $92.14 |
| Q3 2024 | +504 | Add 2.23% | 23,073 | $92.89 |
| Q2 2024 | +9,183 | Add 68.60% | 22,569 | $82.28 |
| Q1 2024 | +2,373 | Add 21.55% | 13,386 | $66.36 |
| Q4 2023 | +2,063 | Add 23.05% | 11,013 | $56.76 |
| Q3 2023 | +1,344 | Add 17.67% | 8,950 | $54.48 |
| Q2 2023 | -687 | Reduce 8.28% | 7,606 | $67.28 |
| Q1 2023 | -82 | Reduce 0.98% | 8,293 | $51.47 |
| Q4 2022 | -5,054 | Reduce 37.63% | 8,375 | $46.02 |
| Q3 2022 | +1,590 | Add 13.43% | 13,429 | $50.71 |
| Q2 2022 | -8,693 | Reduce 42.34% | 11,839 | $45.53 |
| Q1 2022 | -869 | Reduce 4.06% | 20,532 | $46.46 |
| Q4 2021 | -148 | Reduce 0.69% | 21,401 | $50.23 |
| Q3 2021 | +18,270 | Add 557.18% | 21,549 | $53.09 |
| Q2 2021 | -1,309 | Reduce 28.53% | 3,279 | $60.99 |
| Q1 2021 | -1,068 | Reduce 18.88% | 4,588 | $48.82 |
| Q4 2020 | -6,998 | Reduce 55.30% | 5,656 | $40.49 |
| Q3 2020 | -21,397 | Reduce 62.84% | 12,654 | $32.56 |
| Q2 2020 | -2,323 | Reduce 6.39% | 34,051 | $26.40 |
| Q1 2020 | +120 | Add 0.33% | 36,374 | $24.91 |
| Q4 2019 | -5,346 | Reduce 12.85% | 36,254 | $35.94 |
| Q3 2019 | -6,206 | Reduce 12.98% | 41,600 | $34.18 |
| Q2 2019 | -5,411 | Reduce 10.17% | 47,806 | $27.99 |
| Q1 2019 | -3,841 | Reduce 6.73% | 53,217 | $31.01 |
| Q4 2018 | -51,242 | Reduce 47.31% | 57,058 | $23.64 |
| Q3 2018 | -20,520 | Reduce 15.93% | 108,300 | $38.74 |
| Q2 2018 | -17,821 | Reduce 12.15% | 128,820 | $33.48 |
| Q1 2018 | -7,677 | Reduce 4.97% | 146,641 | $36.23 |
| Q4 2017 | -59,306 | Reduce 27.76% | 154,318 | $31.84 |
| Q3 2017 | -55,322 | Reduce 20.57% | 213,624 | $37.42 |
| Q2 2017 | +49,058 | Add 22.31% | 268,946 | $31.22 |
| Q1 2017 | +57,525 | Add 35.43% | 219,888 | $24.63 |
| Q4 2016 | +47,664 | Add 41.56% | 162,363 | $25.34 |
| Q3 2016 | +5,418 | Add 4.96% | 114,699 | $19.84 |
| Q2 2016 | +19,785 | Add 22.11% | 109,281 | $14.27 |
| Q1 2016 | +49,034 | Add 121.19% | 89,496 | $15.52 |
| Q4 2015 | +40,462 | New Buy | 40,462 | $17.25 |
Cliff Asness's LeMaitre Vascular Investment FAQs
Cliff Asness first purchased LeMaitre Vascular, Inc. (LMAT) in Q4 2015, acquiring 40,462 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held LeMaitre Vascular, Inc. (LMAT) for 41 quarters since Q4 2015.
Cliff Asness's largest addition to LeMaitre Vascular, Inc. (LMAT) was in Q1 2017, adding 219,888 shares worth $5.42 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 18,969 shares of LeMaitre Vascular, Inc. (LMAT), valued at approximately $1.54 M.
As of the Q4 2025 filing, LeMaitre Vascular, Inc. (LMAT) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in LeMaitre Vascular, Inc. (LMAT) was 268,946 shares, as reported at the end of Q2 2017.